Skandinaviska Enskilda Banken AB (publ) - AGIOS PHARMACEUTICALS INC ownership

AGIOS PHARMACEUTICALS INC's ticker is AGIO and the CUSIP is 00847X104. A total of 187 filers reported holding AGIOS PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 0.97 and the average weighting 0.1%.

Quarter-by-quarter ownership
Skandinaviska Enskilda Banken AB (publ) ownership history of AGIOS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$1,543
+85.0%
62,360
+112.4%
0.01%
+100.0%
Q2 2023$834
+23.6%
29,3600.0%0.01%0.0%
Q1 2023$675
-22.0%
29,360
-4.6%
0.01%
-28.6%
Q4 2022$865
-99.9%
30,763
-5.5%
0.01%0.0%
Q3 2022$920,000
+27.6%
32,5450.0%0.01%
+40.0%
Q2 2022$721,000
-23.7%
32,5450.0%0.01%
-16.7%
Q1 2022$945,000
-13.4%
32,5450.0%0.01%0.0%
Q4 2021$1,091,000
-27.4%
32,5450.0%0.01%
-25.0%
Q3 2021$1,502,000
-16.2%
32,5450.0%0.01%
-27.3%
Q2 2021$1,793,000
+6.9%
32,5450.0%0.01%0.0%
Q1 2021$1,677,00032,5450.01%
Other shareholders
AGIOS PHARMACEUTICALS INC shareholders Q2 2021
NameSharesValueWeighting ↓
Rock Springs Capital Management LP 2,661,605$61,137,0671.46%
Bellevue Group AG 4,013,500$92,190,0951.34%
Eagle Health Investments LP 267,630$6,147,4611.20%
ARMISTICE CAPITAL, LLC 3,460,000$79,476,2001.14%
Integral Health Asset Management, LLC 213,000$4,892,6100.99%
SUVRETTA CAPITAL MANAGEMENT, LLC 454,000$10,428,3800.44%
ArrowMark Colorado Holdings LLC 1,557,705$35,780,4840.41%
FARALLON CAPITAL MANAGEMENT LLC 2,092,829$48,072,2820.27%
Virtus ETF Advisers LLC 9,932$228,1380.13%
JACOBS LEVY EQUITY MANAGEMENT, INC 614,533$14,115,8230.09%
View complete list of AGIOS PHARMACEUTICALS INC shareholders